Tominaga et al. showed that miR-181c in EVs secreted by highly metastatic breast cancer cells downregulates expression of PDPK1 and inhibits actin polymerization in ECs, thereby disrupting the blood-brain barrier and promoting brain metastasis of breast cancer[64]. This evidence concerns the gene PDPK1 and breast carcinoma.